Compounds > sparfloxacin
Page last updated: 2024-08-24

sparfloxacin and Bacteremia

sparfloxacin has been researched along with Bacteremia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwagaki, A; Matsumoto, K; Nagatake, T; Oishi, K; Pollack, M; Ponglertnapagorn, P; Siadak, A; Sonoda, F; Watanabe, K1
Chongchitmate, A; Rojnpisarnvong, V; Siristonpun, Y; Srimuang, S; Tanphaichitra, D1
Ballow, CH; Deinhart, JA; Johnson, DM; Jones, RN; Schentag, JJ1
Amsterdam, D; Hardy, D; Mandell, LA; Rotstein, C1

Other Studies

4 other study(ies) available for sparfloxacin and Bacteremia

ArticleYear
Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:2

    Topics: Animals; Anti-Infective Agents; Antibodies, Monoclonal; Bacteremia; Cell Movement; Female; Flagella; Fluoroquinolones; Humans; Lipopolysaccharides; Lung; Mice; Mice, Inbred ICR; Neutropenia; Opsonin Proteins; Phagocytosis; Pneumonia; Pseudomonas Infections; Quinolones; Serotyping

1993
In vitro activity of sparfloxacin against selected gram-negative blood culture isolates.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Anti-Infective Agents; Bacteremia; Culture Media; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillins; Quinolones

1995
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Haemophilus; Humans; In Vitro Techniques; Klebsiella; Moraxella catarrhalis; Oxacillin; Quinolones; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; United States

1997
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Fluoroquinolones; Gemifloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines

2000